The First Take: Pearson to be replaced as Valeant CEO but chaos reigns
By Michael Flanagan
Created 03/21/2016 - 16:00
Executive editors Michael Flanagan and Simon King discuss Valeant's announcement that CEO Michael Pearson is to be replaced and whether this will put the company on a firmer footing in light of recent challenges.
FirstWord Pharma is a reliable news service providing an efficient and timely global overview of the news and events impacting the pharmaceutical industry.